Authors:
Girardet, RG
McClain, N
Lahoti, S
Cheung, K
Hartwell, B
McNeese, M
Citation: Rg. Girardet et al., Comparison of the urine-based ligase chain reaction test to culture for detection of Chlamydia trachomatis and Neisseria gronorrhoeae in pediatric sexual abuse victims, PEDIAT INF, 20(2), 2001, pp. 144-147
Authors:
Brito, RA
Valero, V
Buzdar, AU
Booser, DJ
Ames, F
Strom, E
Ross, M
Theriault, RL
Frye, D
Kau, SW
Asmar, L
McNeese, M
Singletary, SE
Hortobagyi, GN
Citation: Ra. Brito et al., Long-term results of combined-modality therapy for locally advanced breastcancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience, J CL ONCOL, 19(3), 2001, pp. 628-633
Authors:
Solin, LJ
Fourquet, A
Vicini, FA
Haffty, B
Taylor, M
McCormick, B
McNeese, M
Pierce, LJ
Landmann, C
Olivotto, IA
Borger, J
Kim, JS
de la Rochefordiere, A
Schultz, DJ
Citation: Lj. Solin et al., Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: Long-term outcome and prognostic significance of patient age and margin status, INT J RAD O, 50(4), 2001, pp. 991-1002
Authors:
Cristofanilli, M
Buzdar, AU
Sneige, N
Smith, T
Wasaff, B
Ibrahim, N
Booser, D
Rivera, E
Murray, JL
Valero, V
Ueno, N
Singletary, ES
Hunt, K
Strom, E
McNeese, M
Stelling, C
Hortobagyi, GN
Citation: M. Cristofanilli et al., Paclitaxel in the multimodality treatment for inflammatory breast carcinoma, CANCER, 92(7), 2001, pp. 1775-1782
Authors:
Vassilopoulou-Sellin, R
Asmar, L
Hortobagyi, GN
Klein, MJ
McNeese, M
Singletary, SE
Theriault, RL
Citation: R. Vassilopoulou-sellin et al., Estrogen replacement therapy after localized breast cancer: Clinical outcome of 319 women followed prospectively, J CL ONCOL, 17(5), 1999, pp. 1482-1487
Authors:
Buzdar, AU
Singletary, SE
Theriault, RL
Booser, DJ
Valero, V
Ibrahim, N
Smith, TL
Asmar, L
Frye, D
Manuel, N
Kau, SW
McNeese, M
Strom, E
Hunt, K
Ames, F
Hortobagyi, GN
Citation: Au. Buzdar et al., Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer, J CL ONCOL, 17(11), 1999, pp. 3412-3417